Trials / Completed
CompletedNCT04809246
Prisons Evaluation of a One-stop-shop InterVentiOn
Prisons Evaluation of a One-stop-shop InterVentiOn to Scale-up Hepatitis C Testing and Treatment (PIVOT)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 541 (actual)
- Sponsor
- Kirby Institute · Other Government
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A prospective historically controlled study to assess the effect of an intervention integrating point-of-care hepatitis C (HCV) RNA testing, non-invasive liver fibrosis assessment, fast-tracked direct-acting antiviral (DAA) prescription, and linkage to hepatitis care (a 'one-stop-shop' intervention), on the proportion of participants initiating DAA therapy among people who are recently incarcerated within reception correctional centre(s) in Australia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 'One-stop-shop' hepatitis clinic | Establishment of a 'one-stop-shop' hepatitis clinic, integrating point-of-care HCV RNA testing, followed by clinical assessment, non-invasive liver fibrosis assessment by fibro-elastography (Fibroscan), and early DAA prescription (for those with chronic HCV) followed by linkage to ongoing hepatitis care, all in the same 60-minute visit. |
Timeline
- Start date
- 2019-10-31
- Primary completion
- 2021-04-23
- Completion
- 2021-09-10
- First posted
- 2021-03-22
- Last updated
- 2022-01-14
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04809246. Inclusion in this directory is not an endorsement.